| Nuclear envelope-related lipodystrophies AC Guenantin, N Briand, G Bidault, P Afonso, V Bereziat, C Vatier, ... Seminars in Cell & Developmental Biology 29, 148-157, 2014 | 73 | 2014 |
| Brown and beige fat: from molecules to physiology and pathophysiology S Carobbio, AC Guénantin, I Samuelson, M Bahri, A Vidal-Puig Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2019 | 72 | 2019 |
| Functional human beige adipocytes from induced pluripotent stem cells AC Guénantin, N Briand, E Capel, F Dumont, R Morichon, C Provost, ... Diabetes 66 (6), 1470-1478, 2017 | 53 | 2017 |
| SREBP1-induced fatty acid synthesis depletes macrophages antioxidant defences to promote their alternative activation G Bidault, S Virtue, K Petkevicius, HE Jolin, A Dugourd, AC Guénantin, ... Nature metabolism 3 (9), 1150-1162, 2021 | 46 | 2021 |
| The lipodystrophic hotspot lamin A p. R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks N Briand, AC Guénantin, D Jeziorowska, A Shah, M Mantecon, E Capel, ... Human molecular genetics 27 (8), 1447-1459, 2018 | 35 | 2018 |
| What the genetics of lipodystrophy can teach us about insulin resistance and diabetes C Vatier, G Bidault, N Briand, AC Guénantin, L Teyssières, O Lascols, ... Current Diabetes Reports 13, 757-767, 2013 | 34 | 2013 |
| Targeting the histone demethylase LSD1 prevents cardiomyopathy in a mouse model of laminopathy AC Guenantin, I Jebeniani, J Leschik, E Watrin, G Bonne, N Vignier, ... The Journal of clinical investigation 131 (1), 2021 | 33 | 2021 |
| Lipodystrophic syndromes due to LMNA mutations: recent developments on biomolecular aspects, pathophysiological hypotheses and therapeutic perspectives C Vigouroux, AC Guénantin, C Vatier, E Capel, C Le Dour, P Afonso, ... Nucleus 9 (1), 251-264, 2018 | 33 | 2018 |
| A cohesin–OCT4 complex mediates Sox enhancers to prime an early embryonic lineage N Abboud, TM Morris, E Hiriart, H Yang, H Bezerra, MG Gualazzi, ... Nature communications 6 (1), 6749, 2015 | 33 | 2015 |
| HIV antiretroviral drugs, dolutegravir, maraviroc and ritonavir-boosted atazanavir use different pathways to affect inflammation, senescence and insulin sensitivity in human … M Auclair, AC Guénantin, S Fellahi, M Garcia, J Capeau PLoS One 15 (1), e0226924, 2020 | 30 | 2020 |
| Unraveling the developmental roadmap toward human brown adipose tissue S Carobbio, AC Guenantin, M Bahri, S Rodriguez-Fdez, F Honig, ... Stem cell reports 16 (3), 641-655, 2021 | 16 | 2021 |
| ‘Basic and applied thermogenesis research’bridging the gap S Carobbio, AC Guénantin, A Vidal-Puig Trends in Endocrinology & Metabolism 29 (1), 5-7, 2018 | 6 | 2018 |
| When oncology research opens a path toward a therapy for a laminopathy AC Guénantin, A Ibre, M Pucéat Medecine Sciences: M/S 37 (10), 836-839, 2021 | | 2021 |
| Cardiomyopathie due à la lamine de type A mutée-Un traitement en vue grâce à la recherche sur le cancer? AC Guénantin, A Ibre, M Pucéat médecine/sciences 37 (10), 836-839, 2021 | | 2021 |
| The antiretroviral drugs dolutegravir, maraviroc and ritonavir-boosted atazanavir could affect inflammation and insulin sensitivity in human coronary endothelial cells through … M Auclair, AC Guenantin, S Fellahi, M Garcia, J Capeau ANTIVIRAL THERAPY 23, A45-A45, 2018 | | 2018 |
| Method for in vitro production of adipocyte progenitors and adipocytes AC Guenantin, N Briand, E Capel, C Vigouroux, J Capeau US Patent App. 15/329,587, 2017 | | 2017 |
| O01 Obtention d’adipocytes beiges humains fonctionnels in vitro et in vivo à partir de cellules souches à pluripotence induite AC Guénantin, N Briand, E Capel, F Stillitano, D Jeziorowska, R Morichon, ... Diabetes & Metabolism 41, A1, 2015 | | 2015 |
| Modélisation d’une laminopathie à partir de cellules souches pluripotentes: Etude phénotypique, génétique et recherche de cibles thérapeutiques AC Guénantin UNIVERSITE D’EVRY VAL D’ESSONNE, 2012 | | 2012 |
| Pluripotent stem cells carrying a mutated LaminA/C: a cell model of laminopathies for the search for new therapeutic targets AC Guenantin, M Bialic, A Bertrand, J Leschick, G Bonne, M Puceat HUMAN GENE THERAPY 23 (10), A44-A44, 2012 | | 2012 |
| Pluripotent Stem Cells: A Cell Model of Laminopathies: Large Scale Genetic and Epigenetic Study, the Search for New Therapeutic Targets AC Guenantin, L Hamon, J Leschik, M Puceat HUMAN GENE THERAPY 20 (6), 688-688, 2009 | | 2009 |
